Syensqo has completed the acquisition of JinYoung Bio, a speciality cosmetic ingredients supplier based in South Korea. The company said that this “marks a significant step in expanding Syensqo’s portfolio toward more natural and high-value speciality skin care solutions with both functional and active ingredients”.

Croda International has bought Solus Biotech from Korea’s Solus Advanced Materials for about $277 million, subject to regulatory approval. Solus Biotech makes biotechnology-derived beauty actives, notably naturally derived powder ceramides and GMP phospholipids for both pharmaceutical and cosmetic applications. Both are high-growth markets, with the number of new personal care products containing ceramides doubling over the last five years.